Mathew, P <br/><br/>
A modular Phase I study of lenalidomide and paclitaxel in metastatic castration-resistant prostate cancer following prior taxane therapy.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Mar 2010 
 - 811-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-009-1237-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anemia--chemically induced<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bridged-Ring Compounds--administration & dosage<br/>Combined Modality Therapy<br/>Diarrhea--chemically induced<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Humans<br/>Lenalidomide<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Neutropenia--chemically induced<br/>Orchiectomy<br/>Paclitaxel--administration & dosage<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Survival Analysis<br/>Taxoids--administration & dosage<br/>Thalidomide--administration & dosage<br/>Treatment Outcome<br/>Vomiting--chemically induced